Helus Pharma (HELP) Stock: Insider Trades, Congress & Funds

Smart money at a glance

Filings to Nov 13, 2026

Net buying: insiders sold $0 and bought $8.3M on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: +$8.3M net
CongressSTOCK Act, 180 days: None
Big funds13F, quarter ended Mar 31, 2026: 0 added, 1 cut
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about HELP filings

Are insiders buying or selling Helus Pharma Inc. (HELP) stock?

Net buying: insiders sold $0 and bought $8.3M of HELP stock on the open market in the 90 days to Nov 13, 2026, according to SEC Form 4 filings. The largest was Glavine, Paul (Chief Growth Officer), who bought $4.7M. The latest filing was on Oct 2, 2026.

Which members of Congress have traded HELP recently?

None. No member of Congress disclosed a HELP trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this HELP smart-money data?

This summary uses filings available on Nov 13, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

Smart money on HELP

Lean long1 source:
- Insiders

Top traders
No tracked positions at the last update
Insiders
Lean long3 buys · $2.5M
Form 4 filings, open market.
Congress
No recent politician filings found
Funds
No recent fund filings found
Influencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about HELP filings

Are insiders buying or selling Helus Pharma Inc. (HELP) stock?

Which members of Congress have traded HELP recently?

None. No member of Congress disclosed a HELP trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this HELP smart-money data?

Insiders

What insiders are doing

8 trades · 6 mo

Bought$8.3M

Buys (3)

CG
Cavers Greg
Chief Financial Officer · Oct 2
$39K
bought
GP
Glavine Paul
Chief Growth Officer · Cluster · Sep 11
$1.2M
bought
Signals like this: n=175, 53% finished lower at D15, median -1.6% vs SPY +0.4%
GP
Glavine Paul
Chief Growth Officer · Cluster · Sep 11
$1.2M
bought

2 more trades

Pro opens all of them for $16.50/month, paid yearly.

Unlock all 2 trades

Unlock everything for $29/month

Unlock for $29/month

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Jul 22, 2022

Period ending

Mar 31, 2022

Earnings per share

Unavailable

EPS comparison unavailable

Revenue (FY)

CAD 0.00

Year ended Mar 31, 2022 · SEC filing

Next report

What the street expects next

Estimates as of Nov 13, 2026

EPS expected

-$0.95

-$1.33 to -$0.58

Last 30 days

1up1down

Split both ways

Estimate drift

0.07

Change in 30 days

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 12, 2026	Not on file	No estimate	Not on file	Not on file
Jun 30, 2026Reported Aug 14, 2026	-$1.26est. -$1.38	+8.37%beat	Not on file	Not on file
Mar 31, 2026Reported Jun 29, 2026	-$1.21est. -$1.14	-5.77%miss	$0.00Yahoo Finance	No year-ago quarter
Dec 31, 2025Reported Feb 13, 2026	-$1.36est. -$0.98	-39.79%miss	$0.00Yahoo Finance	No year-ago quarter
Sep 30, 2025Reported Nov 13, 2025	-$1.65est. -$1.33	-24.53%miss	$0.00Yahoo Finance	No year-ago quarter
Jun 30, 2025Reported Aug 13, 2025	-$0.97est. -$1.10	+11.98%beat	Not on file	Not on file
Mar 31, 2025Reported Jun 30, 2025	-$1.46est. -$1.23	-18.70%miss	Not on file	Not on file
Dec 31, 2024Reported Feb 10, 2025	-$0.53est. -$1.57	+66.24%beat	Not on file	Not on file

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $9.07
High: $9.35
Low: $8.78
Prev close: $9.39
52-wk high: $15.15
52-wk low: $3.76
Mkt cap: $686.0M
ROE: -86.9%
Beta: 0.62
P/S: 16436.4x
P/B: 2.7x
Profit margin: +0.0%
Op margin: +0.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $686M

Valuation

P/S16436.36
P/B2.74

Quality

Operating margin0.0%
ROE-86.9%
ROA-44.4%

Growth

Beta0.62

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

25 / 100

RSI 14

39balanced

20D volatility

85%annualized

52-week range

$8.86

$3.76$15.15

20D support

$8.20recent floor

20D resistance

$11.74recent ceiling

Returns

5D +5.6%20D -19.8%60D -24.8%

Price vs moving averages

SMA20 -10.2%SMA50 -21.6%SMA200 +13.9%

Volume pace

0.82xvs prior 20D

Quarter / reported

Earnings per share

Beat or miss

Revenue / income

Revenue vs last year

Sep 30, 2026Nov 12, 2026

Not on file

No estimate

Not on file

Jun 30, 2026Aug 14, 2026

-$1.26est. -$1.38

+8.37%

Not on file

Mar 31, 2026Jun 29, 2026

-$1.21est. -$1.14

-5.77%

$0.00Yahoo Finance

No year-ago quarter

Dec 31, 2025Feb 13, 2026

-$1.36est. -$0.98

-39.79%

$0.00Yahoo Finance

No year-ago quarter

Sep 30, 2025Nov 13, 2025

-$1.65est. -$1.33

-24.53%

$0.00Yahoo Finance

No year-ago quarter

Jun 30, 2025Aug 13, 2025

-$0.97est. -$1.10

+11.98%

Not on file

Mar 31, 2025Jun 30, 2025

-$1.46est. -$1.23

-18.70%

Not on file

Dec 31, 2024Feb 10, 2025

-$0.53est. -$1.57

+66.24%

Not on file

Helus Pharma Inc.

Smart money at a glance

What do analysts expect?

Questions about HELP filings

Smart money on HELP

Questions about HELP filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Results versus expectations

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Helus Pharma Inc.

Smart money at a glance

What do analysts expect?

Questions about HELP filings

Smart money on HELP

Questions about HELP filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Results versus expectations

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Helus Pharma Inc.

Overview

Questions about HELP filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Helus Pharma Inc.

Overview

Questions about HELP filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.